Finny logo
Finny logo
Dibs:
Dibs:
0

Xenetic Biosciences (XBIO): headed for the sky?

1:42 pm ET, 21 Jun 2018

Xenetic Biosciences, Inc. (XBIO) shares are trading at 6.43, up 169% from yesterday.  There are no apparent news driving the price of shares up.  What is the XBIO stock price forecast? 

Let's look into the technical analysis for XBIO to better understand investors' sentiment. The short-term price sentiment appears to be very strong. Mid-term-wise, the stock looks more neutral, while the long-term outlook seems to be very solid.  

The XBIO stock is considered nanocap, so any larger trading volume can cause a significant price spike.  The current volume is more than double the normal volume, while the turnover of shares is fairly small. No particular news accounts for the action.

At the end March, the company had ~$3.9M in cash while operations consumed ~$1.7M in Q1.

Over the last month, not inclusive of today, Xenetic Biosciences, Inc. (XBIO) returned +38.15%.

Xenetic Biosciences is a clinical-stage biopharmaceutical company that focuses on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. The company's lead investigational product candidate is oncology therapeutic XBIO-101 (sodium cridanimod) for the treatment of progesterone resistant endometrial cancer. Its proprietary drug development platform, PolyXen, enables next-generation biologic drugs by improving their half-life and other pharmacological properties. 

For the latest price and information on Xenetic Biosciences, Inc., please visit Finstead and search for "XBIO price" or "XBIO news".

Xenetic Biosciences, Inc. (XBIO) Stock Guide

Updated at: 3:53 pm ET, 13 Jan 2021

Before we start: if you're looking for XBIO stock price, you can quickly find it out by visiting Finny and typing "XBIO quote". If you're looking for a quick scoop on XBIO stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "XBIO". You'll get all this info in one place. Or you can just type "XBIO news" to get the latest stock news.

Looking to buy or sell Xenetic Biosciences, Inc. (XBIO)? Interested in getting the full scoop on XBIO, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this XBIO stock guide, we'll address key questions about XBIO, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are XBIO earnings?
2. When is XBIO earnings date?
3. XBIO buy or sell? What is XBIO Finny Score?
4. What are the reasons to buy XBIO? Why should I buy XBIO stock?
5. What are the reasons to sell XBIO? Why should I sell XBIO stock?
6. What are XBIO key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are XBIO earnings?

XBIO trailing 12-month earnings per share (EPS) is -$1.76.

2. When is XBIO earnings date?

XBIO earnings date is November 13, 2020.

Analysis

3. XBIO buy or sell? What is XBIO Finny Score?

#{finnyScore:80}Our quantitative analysis shows 4 reasons to buy and 1 reason to sell XBIO, resulting in Finny Score of 80.

4. What are the reasons to buy XBIO? Why should I buy XBIO stock?

Here are the reasons to buy XBIO stock:

5. What are the reasons to sell XBIO? Why should I sell XBIO stock?

Let's look at the reasons to sell XBIO stock (i.e., the bear case):

  • XBIO short share of float is 6.58%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See XBIO short share of float chart.

Key Stats

6. What are XBIO key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for XBIO:

Metrics XBIO
Price $2.52
Average Price Target / Upside N/A
Average Analyst Rating Strong Buy
Forward Dividend Yield 0.00%
Industry Biotechnology
Sector Healthcare
Number of Employees 5
Market Cap $25.19M
Forward P/E Ratio -4.24
Price/Book Ratio 83.21
Revenue (TTM) $302.68K
YoY Quarterly Revenue Growth N/A
Profit Margin 0.00%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us